Cite
HARVARD Citation
Durongpisitkul, K. et al. (2021). Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study. JRSM cardiovascular disease. p. . [Online].